Elkfork Partners’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$18.9M Sell
208,714
-11,880
-5% -$1.35M 0.46% 54
2019
Q2
$26M Sell
220,594
-20,020
-8% -$2.02M 0.64% 35
2019
Q1
$20.8M Sell
240,614
-1,804
-0.7% -$154K 0.52% 43
2018
Q4
$15.3M Sell
242,418
-1,540
-0.6% -$106K 0.43% 52
2018
Q3
$19.3M Buy
243,958
+27,368
+13% +$1.78M 0.46% 56
2018
Q2
$12.9M Sell
216,590
-10,098
-4% -$543K 0.33% 71
2018
Q1
$9.14M Buy
226,688
+7,502
+3% +$366K 0.25% 86
2017
Q4
$11.5M Sell
219,186
-9,020
-4% -$482K 0.31% 70
2017
Q3
$10.8M Buy
228,206
+4,158
+2% +$167K 0.31% 68
2017
Q2
$7.92M Buy
224,048
+55,616
+33% +$1.72M 0.24% 87
2017
Q1
$3.98M Buy
168,432
+44,550
+36% +$883K 0.12% 156
2016
Q4
$1.66M Buy
+123,882
New +$2M 0.05% 237

Other funds holding EXAS

Elkfork Partners's EXAS Position: Q3 2019 in Review

Elkfork Partners reduced its Exact Sciences (EXAS) stake by 5.4% in Q3 2019, selling an estimated $1.35M and leaving 208,714 shares worth $18.9M. The position accounts for 0.46% of the portfolio, ranked #54.

Elkfork Partners first reported a position in EXAS in Q4 2016 and has held it in 12 quarters since. The position peaked at $26M in Q2 2019. 475 funds tracked by Wall St. Rank hold EXAS as of Q3 2019.

  • Elkfork Partners held 208,714 shares of Exact Sciences worth $18.9M as of Q3 2019.
  • Elkfork Partners sold 11,880 Exact Sciences shares in Q3 2019, an estimated $1.35M.
  • Exact Sciences made up 0.46% of Elkfork Partners's portfolio in Q3 2019, its #54 holding.
  • Elkfork Partners first reported a position in Exact Sciences in Q4 2016 and has held it in 12 quarters since.
  • Elkfork Partners's Exact Sciences position peaked at $26M in Q2 2019.
  • 475 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.